Overview: Rubella IgG Avidity TestIntroduction: The Rubella IgG Avidity Test measures rubella IgG avidity to determine recent or past infection, preventing congenital defects. Aligned with 2023 CDC guidelines, it uses immunoassays for high specificity, supporting infection screening. This test is critical for guiding diagnosis, pregnancy management, and improving outcomes in immunology for patients with suspected rubella exposure.
Other Names: Rubella Avidity Assay, Rubella IgG Binding Test.
FDA Status: Laboratory-developed test (LDT), meeting immunology standards for diagnostic accuracy.
Historical Milestone: Rubella avidity testing began in the 1980s with congenital rubella research. Immunoassay methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures rubella IgG avidity to determine recent or past infection, guides treatment, and prevents congenital defects.
Test Parameters: 1. Rubella IgG Avidity
Pretest Condition: No fasting required. Collect serum or saliva. Report history of rubella exposure or vaccination.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document rubella exposure, vaccination, or pregnancy status. Include current medications, especially immunosuppressants.
Consent: Written consent required, detailing the tests purpose, rubella infection implications, and risks of sample collection.
Procedural Considerations: Uses enzyme-linked immunosorbent assay (ELISA) to measure rubella IgG avidity. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for rubella infection timing.
Factors Affecting Result Accuracy: Sample hemolysis or improper storage can affect results. Early testing may yield low avidity falsely.
Clinical Significance: Low avidity indicates recent infection, guiding pregnancy management. High avidity confirms past infection or immunity.
Specialist Consultation: Consult an obstetrician or infectious disease specialist for result interpretation and treatment planning.
Additional Supporting Tests: Rubella IgM, PCR, or ultrasound to confirm rubella infection timing.
Test Limitations: Avidity interpretation requires clinical correlation. Sample quality affects sensitivity.
References: CDC Rubella Guidelines, 2023; Journal of Clinical Virology, Thomas HIJ, 2022.
